Cysteine and methionine oxidation in thrombotic disorders.

Benzothiazine Beta-2 glycoprotein I Cysteine Disulfide Fibrinogen Glutathionylation Hemostasis Methionine Methionine sulfoxide Methionine sulfoxide reductase Nitrosation Oxaziridine Oxidation Protein disulfide isomerase Src kinase Sulfenylation Sulfhydration Thrombosis von Willebrand factor

Journal

Current opinion in chemical biology
ISSN: 1879-0402
Titre abrégé: Curr Opin Chem Biol
Pays: England
ID NLM: 9811312

Informations de publication

Date de publication:
10 2023
Historique:
received: 27 04 2023
revised: 19 05 2023
accepted: 22 05 2023
pmc-release: 01 10 2024
medline: 22 9 2023
pubmed: 19 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

Thrombosis is the leading cause of death in many diseased conditions. Oxidative stress is characteristic of these conditions. Yet, the mechanisms through which oxidants become prothrombotic are unclear. Recent evidence suggests protein cysteine and methionine oxidation as prothrombotic regulators. These oxidative post-translational modifications occur on proteins that participate in the thrombotic process, including Src family kinases, protein disulfide isomerase, β2 glycoprotein I, von Willebrand factor, and fibrinogen. New chemical tools to identify oxidized cysteine and methionine proteins in thrombosis and hemostasis, including carbon nucleophiles for cysteine sulfenylation and oxaziridines for methionine, are critical to understanding why clots occur during oxidative stress. These mechanisms will identify alternative or novel therapeutic approaches to treat thrombotic disorders in diseased conditions.

Identifiants

pubmed: 37331217
pii: S1367-5931(23)00088-1
doi: 10.1016/j.cbpa.2023.102350
pmc: PMC10527720
mid: NIHMS1910280
pii:
doi:

Substances chimiques

Methionine AE28F7PNPL
Cysteine K848JZ4886
Proteins 0
Racemethionine 73JWT2K6T3

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102350

Subventions

Organisme : NHLBI NIH HHS
ID : K99 HL164888
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM128840
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Biochem Pharmacol. 2006 Aug 28;72(5):608-15
pubmed: 16815310
Blood Rev. 2020 Jan;39:100610
pubmed: 31471128
Blood. 2017 May 25;129(21):2917-2927
pubmed: 28336528
Crit Rev Clin Lab Sci. 2019 Dec;56(8):511-525
pubmed: 31448653
Chem Res Toxicol. 2017 Mar 20;30(3):729-762
pubmed: 28122179
Antioxid Redox Signal. 2021 Nov 1;35(13):1116-1133
pubmed: 33940944
Nat Rev Mol Cell Biol. 2022 Jul;23(7):499-515
pubmed: 35190722
Int J Mol Sci. 2022 Oct 23;23(21):
pubmed: 36361561
Nat Commun. 2018 Oct 30;9(1):4522
pubmed: 30375386
Proteins. 2021 Jun;89(6):731-741
pubmed: 33550613
J Biol Chem. 2021 Aug;297(2):100890
pubmed: 34197876
Biophys J. 2012 Dec 5;103(11):2399-407
pubmed: 23283239
Free Radic Biol Med. 2019 May 20;136:159-171
pubmed: 30825500
Cell Tissue Res. 2022 Mar;387(3):391-398
pubmed: 34014399
Sci Rep. 2021 Feb 25;11(1):4542
pubmed: 33633190
Res Pract Thromb Haemost. 2019 Mar 04;3(2):161-172
pubmed: 31011700
Blood Adv. 2018 Nov 13;2(21):2848-2861
pubmed: 30381401
Acc Chem Res. 2020 Jan 21;53(1):20-31
pubmed: 31869209
Sci Rep. 2019 Jan 14;9(1):115
pubmed: 30643157
J Clin Invest. 2008 Mar;118(3):1123-31
pubmed: 18292814
Platelets. 2014;25(3):166-74
pubmed: 23586391
Biomol Ther (Seoul). 2017 May 1;25(3):223-230
pubmed: 27871158
Free Radic Biol Med. 2005 Jun 1;38(11):1501-10
pubmed: 15890624
Science. 2017 Feb 10;355(6325):597-602
pubmed: 28183972
Cells. 2022 Nov 21;11(22):
pubmed: 36429131
Biochemistry. 2010 Sep 7;49(35):7748-55
pubmed: 20712299
Blood. 2011 Nov 10;118(19):5283-91
pubmed: 21917758
Blood. 1997 Jul 1;90(1):204-8
pubmed: 9207454
Curr Opin Chem Biol. 2012 Dec;16(5-6):498-506
pubmed: 23127359
J Clin Invest. 2008 Mar;118(3):1110-22
pubmed: 18274674
Redox Biol. 2022 Apr;50:102244
pubmed: 35077997
Methods Enzymol. 2015;555:39-56
pubmed: 25747474
Redox Biol. 2021 May;41:101934
pubmed: 33765616
Free Radic Biol Med. 2013 Dec;65:411-418
pubmed: 23851017
Blood Adv. 2020 Sep 22;4(18):4494-4507
pubmed: 32946569
J Thromb Haemost. 2018 Nov;16(11):2322-2335
pubmed: 30207066
J Biol Chem. 2019 Feb 22;294(8):2949-2960
pubmed: 30635401
Int J Mol Sci. 2020 Nov 27;21(23):
pubmed: 33260972
Antioxid Redox Signal. 2021 Nov 1;35(13):1134-1155
pubmed: 34121445
Antioxidants (Basel). 2021 Apr 29;10(5):
pubmed: 33946846
Annu Rev Biophys. 2011;40:169-86
pubmed: 21314430
Blood. 2010 Sep 16;116(11):1995-7
pubmed: 20847215
J Thromb Haemost. 2017 Apr;15(4):774-784
pubmed: 28109047
Arch Biochem Biophys. 2017 Mar 1;617:9-25
pubmed: 27697462
Circ Res. 2016 Apr 29;118(9):1340-7
pubmed: 27126645
Eur J Cell Biol. 2022 Jun-Aug;101(3):151249
pubmed: 35716426
J Autoimmun. 2022 Jan;126:102747
pubmed: 34794103
Antioxidants (Basel). 2021 Nov 09;10(11):
pubmed: 34829661
Sci Rep. 2021 Aug 3;11(1):15691
pubmed: 34344919
Blood. 2010 Sep 16;116(11):1961-70
pubmed: 20551379
J Thromb Haemost. 2023 Aug;21(8):2137-2150
pubmed: 37037379
Int J Mol Sci. 2020 Jun 15;21(12):
pubmed: 32549393
Angew Chem Int Ed Engl. 2014 Jan 7;53(2):575-81
pubmed: 24288186
Antioxid Redox Signal. 2019 Jul 1;31(1):1-38
pubmed: 29790379
J Thromb Haemost. 2021 Jan;19(1):233-247
pubmed: 33047470
Chem Rev. 2013 Jul 10;113(7):4633-79
pubmed: 23514336
Nat Med. 2007 Sep;13(9):1086-95
pubmed: 17721545
Blood Adv. 2023 Apr 25;7(8):1366-1378
pubmed: 36219587
Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1798-804
pubmed: 26069236
Blood. 2015 Jun 18;125(25):3851-9
pubmed: 25900980
Nitric Oxide. 2017 Feb 28;63:52-60
pubmed: 27720836
Res Pract Thromb Haemost. 2021 Mar 26;5(3):376-389
pubmed: 33870023
J Autoimmun. 2022 Apr;128:102813
pubmed: 35247655
Blood. 2019 Feb 14;133(7):743-753
pubmed: 30504459
J Am Chem Soc. 2022 Dec 21;144(50):22890-22901
pubmed: 36484997
Blood. 2015 Apr 23;125(17):2693-703
pubmed: 25710879
J Biol Chem. 2022 Aug;298(8):102217
pubmed: 35780832
J Thromb Haemost. 2009 Jul;7 Suppl 1:24-7
pubmed: 19630761
J Biol Chem. 2015 Jan 16;290(3):1422-31
pubmed: 25422322

Auteurs

Moua Yang (M)

Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA. Electronic address: myang4@bidmc.harvard.edu.

Brian C Smith (BC)

Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: brismith@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH